A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease
Clinical trial NCT04658186 · COMPLETED
Trial details
- NCT number
- NCT04658186
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2024-09-06
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.